AR and hepatocellular carcinoma: Since the vascular endothelial growth factor (VEGF) is a target gene of AR in the liver and plays an important role in tumor angiogenesis, the increased transcriptional activity of AR leads to higher risk of developing HCC in HCV-infected patients.